Ads
related to: t-cell therapy- How This Treatment Works
Get Info On Lymphoma
Treatment & See How It Works
- Safety & Side Effects
Read Important Safety And Possible
Side Effects Information.
- Treatment Centers
Find A Treatment Center Near You
FDA-Approved Treatment Option
- Take The Quiz
Find Out If This Treatment Option
Is Right For You
- Real Patient Stories
Hear How Cell Therapy Could Help
From Real Patients And Caregivers
- Care Partner Support
Find Out More About
Lymphoma Treatment Options
- How This Treatment Works
Search results
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
WROC Rochester· 3 days agoUSA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years...
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
InvestorPlace· 11 hours agoThanks to biotech companies that produce transformative drugs and treatments, we now have the collective ability to combat diseases that used to bring...
New immunotherapy could treat cancer in the bone
Medical Xpress· 2 days agoOsteosarcoma is the most common bone cancer in teenagers but is still relatively rare, with around 160 new cases each year in the UK. Meanwhile, more...
Gene variants foretell the biology of future breast cancers, study finds
Medical Xpress· 12 hours agoThe study challenges the dogma that most cancers arise as the result of random mutations that accumulate during our lifetimes. Instead, it points to the active involvement of gene sequences ...
Soterios sees phase 2 win for alopecia cream as offering alternative to JAK domination
FierceBiotech· 18 hours agoWhatever the science, it seems to have done the job in a phase 2 trial, at least when it came to one...
AbelZeta Announces Publication of Abstract for ASCO 2024 Annual Meeting
WKRN Nashville· 7 days agoAbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 6 days agoIovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. The Iovance TIL platform ...
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 2 days agoOXFORDSHIRE, England & CONSHOHOCKEN, PA & ROCKVILLE, MD - Immunocore Holdings plc (NASDAQ:IMCR), a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with FDA, all patients randomized from start of TEBE-AM
Biologics Improve Outcomes in Patients With COPD, Asthma
Medscape· 3 days agoA diverse and refractory patient population showed significant improvements within a year of...
Ad
related to: t-cell therapy
